Predicting Type 2 Diabetes Remission and Relapse After Metabolic-Bariatric Surgery and Lifestyle Therapy: Insights from the ARMMS-T2D Study

Highlight

  • Metabolic-bariatric surgery (MBS) achieved diabetes remission in 58% of patients versus 3% with medical-lifestyle therapy over 11 years.
  • Shorter diabetes duration and absence of insulin use strongly predict sustained remission post-MBS.
  • Early weight loss within one year post-MBS is a critical factor associated with remission success.
  • Longer diabetes duration and more glucose-lowering medications increase risk of relapse after remission.

Study Background

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply